|
|
|
||||||||||
Associate Professor, School of Pharmacy, Northeastern University, 206 Mugar Life Sciences Bldg., Boston, Massachusetts 02115-5000, fax 617/373-7655, j.devlin{at}neu.edu
Professor, College of Pharmacy/Department of Pharmacy Practice, University of Nebraska Medical Center, Omaha, Nebraska
Published Online, April 11, 2006. www.theannals.com, DOI 10.1345/aph.1G126b
8
French).
We agree that the very small particle size of the immediate-release
omeprazole formulation is unlikely to result in tube occlusion. While it is
interesting to learn that no patients in Dr. Conrad's study developed tube
obstruction, it is important to note that PPI delivery was not formally
evaluated in the study, and it remains unclear whether narrow-caliber feeding
tubes (eg,
8 French) were
used.1 The
best evidence to support the administration of immediate-release omperazole
through narrow-caliber feeding tubes comes from an vitro study that evaluated
the ability of 16 nurses and lay people to deliver immediate-release
omeprazole through an 8 French caliber
tube.2 Using
HPLC techniques to quantify delivery, we found that an average ± SD of
96 ± 3% of each dose of immediate-release omeprazole was delivered
through the tube. In summary, we agree with the conclusions of Dr. Conrad that
immediate-release omeprazole (with sodium bicarbonate) may be administered
through orogastric tubes with little, if any, risk for tube occlusion.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||